 | • レポートコード：MRC2302C077 • 出版社/出版日：360iResearch / 2023年2月3日 • レポート形態：英語、PDF、241ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社では、2021年に3,608.18百万ドルであった世界の人工血管市場規模が、2022年に3,886.11百万ドルに達し、2027年には年平均成長率7.87%で5,687.58百万ドルまで成長すると予測しています。当調査レポートでは、人工血管の世界市場の現状について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、競争状況などの構成でまとめております。セグメント分析では、原材料別（生体材料、ポリエステル、ポリテトラフルオロエチレン、ポリウレタン）、製品別（冠動脈バイパスグラフト、血管内ステントグラフト、血液透析アクセスグラフト、末梢血管用グラフト）、用途別（動脈瘤、心臓血管、糖尿病、腎不全、血管閉塞）、エンドユーザー別（外来手術センター、病院）、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）の情報が含まれています。なお、当市場の主要企業には、AB Rėkyva、AS Tootsi Turvas、Berger Peat Moss、Bord na Móna、Cocogreen (UK) LTD.、Dutch Plantin Coir India Pvt. Ltd.、Elva E.P.T. Ltd.、Global Peat Ltd.、Jiffy Group、klasmann-Deilmann GmbH、Kumaran Fibres、Neova Oy、Oulun Energia Oy、Peat Land Ukraine LLC、Premier Tech Horticulture、Sun Gro Horticultureなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の人工血管市場規模：原材料別 - 生体材料由来の市場規模 - ポリエステル由来の市場規模 - ポリテトラフルオロエチレン由来の市場規模 - ポリウレタン由来の市場規模 ・世界の人工血管市場規模：製品別 - 冠動脈バイパスグラフトの市場規模 - 血管内ステントグラフトの市場規模 - 血液透析アクセスグラフトの市場規模 - 末梢血管用グラフトの市場規模 ・世界の人工血管市場規模：用途別 - 動脈瘤における市場規模 - 心臓血管における市場規模 - 糖尿病における市場規模 - 腎不全における市場規模 - 血管閉塞における市場規模 ・世界の人工血管市場規模：エンドユーザー別 - 外来手術センターにおける市場規模 - 病院における市場規模 ・世界の人工血管市場規模：地域別 - 南北アメリカの人工血管市場規模 アメリカの人工血管市場規模 カナダの人工血管市場規模 ブラジルの人工血管市場規模 … - アジア太平洋の人工血管市場規模 日本の人工血管市場規模 中国の人工血管市場規模 インドの人工血管市場規模 韓国の人工血管市場規模 台湾の人工血管市場規模 … - ヨーロッパ/中東/アフリカの人工血管市場規模 イギリスの人工血管市場規模 ドイツの人工血管市場規模 フランスの人工血管市場規模 ロシアの人工血管市場規模 … - その他地域の人工血管市場規模 ・競争状況 ・企業情報 |
The Global Vascular Graft Market size was estimated at USD 3,608.18 million in 2021 and expected to reach USD 3,886.11 million in 2022, and is projected to grow at a CAGR 7.87% to reach USD 5,687.58 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Vascular Graft to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Raw Material, the market was studied across Biological Materials, Polyester, Polytetrafluoroethylene, and Polyurethane.
Based on Product, the market was studied across Coronary Artery By-Pass Graft, Endovascular Stent Graft, Hemodialysis Access Graft, and Peripheral Vascular Grafts.
Based on Application, the market was studied across Aneurysm, Cardiovascular, Diabetes, Kidney Failure, and Vascular Occlusion.
Based on End User, the market was studied across Ambulatory Surgical Center and Hospital.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Vascular Graft market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vascular Graft Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vascular Graft Market, including Abbott Laboratories, Affluent Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, BIOVIC Sdn Bhd, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., CryoLife, Inc., Endologix Inc., Getinge AB, Heart Medical Europe BV., Japan Lifeline Co., Ltd, Laboratory Corporation of America Holdings, Lemaitre Vascular, Inc., Lombard Medical, Inc., Maquet Holding B.V. & Co. Kg, Medtronic PLC, Shanghai Suokang Medical Implants Co., Ltd., Terumo Corporation, Vascular Graft Solutions Ltd, Vygon SA, and W. L. Gore & Associates, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Vascular Graft Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vascular Graft Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vascular Graft Market?
4. What is the competitive strategic window for opportunities in the Global Vascular Graft Market?
5. What are the technology trends and regulatory frameworks in the Global Vascular Graft Market?
6. What is the market share of the leading vendors in the Global Vascular Graft Market?
7. What modes and strategic moves are considered suitable for entering the Global Vascular Graft Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number chronic diseases worldwide
5.1.1.2. Growing number of end-stage renal disorders in developing economies
5.1.1.3. Surge prevalence of end stage renal disease (ESRD)
5.1.2. Restraints
5.1.2.1. High treatment cost and infections associated with vascular grafts
5.1.3. Opportunities
5.1.3.1. Increasing patients awareness and high demand from developing countries
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals and low penetration of reimbursement
5.2. Cumulative Impact of COVID-19
6. Vascular Graft Market, by Raw Material
6.1. Introduction
6.2. Biological Materials
6.3. Polyester
6.4. Polytetrafluoroethylene
6.5. Polyurethane
7. Vascular Graft Market, by Product
7.1. Introduction
7.2. Coronary Artery By-Pass Graft
7.3. Endovascular Stent Graft
7.4. Hemodialysis Access Graft
7.5. Peripheral Vascular Grafts
8. Vascular Graft Market, by Application
8.1. Introduction
8.2. Aneurysm
8.3. Cardiovascular
8.4. Diabetes
8.5. Kidney Failure
8.6. Vascular Occlusion
9. Vascular Graft Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Center
9.3. Hospital
10. Americas Vascular Graft Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Vascular Graft Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Vascular Graft Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Affluent Medical
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. B. Braun Melsungen AG
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Becton, Dickinson and Company
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. BIOVIC Sdn Bhd
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Boston Scientific Corporation
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Cardinal Health Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Cook Medical, Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. CryoLife, Inc.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Endologix Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Getinge AB
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Heart Medical Europe BV.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Japan Lifeline Co., Ltd
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Laboratory Corporation of America Holdings
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Lemaitre Vascular, Inc.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Lombard Medical, Inc.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Maquet Holding B.V. & Co. Kg
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Medtronic PLC
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Shanghai Suokang Medical Implants Co., Ltd.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Terumo Corporation
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Vascular Graft Solutions Ltd
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Vygon SA
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. W. L. Gore & Associates, Inc.
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing